Characterisation and antidiabetic utility of a novel hybrid peptide, exendin-4/gastrin/xenin-8-Gln

This publication has 64 references indexed in Scilit:

• Central action of xenin affects the expression of lipid metabolism-related genes and proteins in mouse white adipose tissue
  Neuropeptides, 2017
• Glucose-dependent Insulinotropic Polypeptide: Blood Glucose Stabilizing Effects in Patients With Type 2 Diabetes
  The Journal of Clinical Endocrinology & Metabolism, 2014
• Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
  Cell Metabolism, 2013
• A DPP-IV-resistant triple-acting agonist of GIP, GLP-1 and glucagon receptors with potent glucose-lowering and insulinotropic actions in high-fat-fed mice
  Diabetologia, 2013
• Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contents
  Biochemical and Biophysical Research Communications, 2009
• Effects of beta-cell rest on beta-cell function: a review of clinical and preclinical data
  Pediatric Diabetes, 2008
• Xenin reduces feed intake by activating the ventromedial hypothalamus and influences gastrointestinal transit rate in chicks
  Behavioural Brain Research, 2007
• Preservation of Pancreatic β-Cell Function and Prevention of Type 2 Diabetes by Pharmacological Treatment of Insulin Resistance in High-Risk Hispanic Women
  Diabetes, 2002
• Physiological Role of Cholecystokinin B/Gastrin Receptor in Leptin Secretion1
  Endocrinology, 1999
• Xenin—a novel suppressor of food intake in rats
  Brain Research, 1998